CA Patent

CA2631233A1 — Ganaxolone formulations and methods for the making and use thereof

Assigned to Immedica Pharma US Inc · Expires 2007-05-31 · 19y expired

What this patent protects

In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.

USPTO Abstract

In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.

Drugs covered by this patent

Patent Metadata

Patent number
CA2631233A1
Jurisdiction
CA
Classification
—
Expires
2007-05-31
Drug substance claim
No
Drug product claim
No
Assignee
Immedica Pharma US Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.